Oligomeric compounds for the modulation HIF-1alpha expression

Details for Australian Patent Application No. 2003225495 (hide)

Owner Santaris Pharma A/S Enzon Pharmaceuticals, Inc.

Inventors Thrue, Charlotte Albaek; Kristjansen, Paul E G; HoG, Anja Molhart

Agent Cullen & Co

Pub. Number AU-B-2003225495

PCT Number PCT/IB03/01758

PCT Pub. Number WO2003/085110

Priority 60/370,126 05.04.02 US

Filing date 4 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 15 January 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/370,126 05.04.02 US

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003225495

13 September 2007 Assignment before Grant

  Santaris Pharma A/S The application has been assigned to Santaris Pharma A/S; Enzon Pharmaceuticals, Inc.

15 January 2009 Application Accepted

  Published as AU-B-2003225495

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225496-A PHOSPHOR SCREEN OF A CATHODE RAY TUBE AND A METHOD OF MANUFACTURING SAME

2003225494-ALIGNMENT TOOL, ASSEMBLY TOOL AND METHOD FOR A POLYPLANE WORKPIECE